Syra Health Corp [NASDAQ: SYRA] price surged by 50.70 percent to reach at $0.25.
The one-year SYRA stock forecast points to a potential upside of 58.89.
Guru’s Opinion on Syra Health Corp [SYRA]:
The Average True Range (ATR) for Syra Health Corp is set at 0.08, with the Price to Sales ratio for SYRA stock in the period of the last 12 months amounting to 0.94. The Price to Book ratio for the last quarter was 2.17, with the Price to Cash per share for the same quarter was set at 0.28.
SYRA Stock Performance Analysis:
Syra Health Corp [SYRA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 70.97. With this latest performance, SYRA shares gained by 83.64% in over the last four-week period, additionally sinking by -46.09% over the last 6 months – not to mention a drop of -29.66% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SYRA stock in for the last two-week period is set at 83.11, with the RSI for the last a single of trading hit 89.07, and the three-weeks RSI is set at 76.44 for Syra Health Corp [SYRA]. The present Moving Average for the last 50 days of trading for this stock 0.4158, while it was recorded at 0.5060 for the last single week of trading, and 0.9450 for the last 200 days.
Insight into Syra Health Corp Fundamentals:
Syra Health Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.63 and a Current Ratio set at 4.63.
Syra Health Corp [SYRA] Institutonal Ownership Details
There are presently around $7.86%, or 9.48%% of SYRA stock, in the hands of institutional investors.
